---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-025960"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2025-12-03T23:59:59+00:00"
generated_at: "2026-05-16T15:00:30.843711+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Interpace Biosciences fully repays BroadOak term loan early, strengthens balance sheet

## Summary
- Fully repaid outstanding term loan facility with BroadOak Capital Partners prior to maturity.
- Original Loan and Security Agreement dated October 29, 2021 with BroadOak Fund V, L.P.
- Early repayment eliminates related interest expenses, increasing operational flexibility.
- CFO Chris McCarthy says repayment reflects robust financial performance and disciplined capital management.
- Company now focused on driving commercial growth and record testing volumes/revenue for thyroid tests.

## SEC filing metadata
- accession: 0001493152-25-025960
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2025-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315225025960/0001493152-25-025960-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315225025960/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-025960
- JSON: https://secwatch.observer/filing/0001493152-25-025960.json
- Plain text: https://secwatch.observer/filing/0001493152-25-025960.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.